Evidence map›Paper›PMID 23978446›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2013

Fast metabolic response to drug intervention through analysis on a miniaturized, highly integrated molecular imaging system.

Jun Wang, Kiwook Hwang, Daniel Braas, Alex Dooraghi, David Nathanson, Dean O Campbell, Yuchao Gu, Troy Sandberg, Paul Mischel, Caius Radu and 4 more

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jun WangNSB Cancer Center, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California.
Kiwook Hwang
Daniel Braas
Alex Dooraghi
David Nathanson
Dean O Campbell
Yuchao Gu
Troy Sandberg
Paul Mischel
Caius Radu
Arion F Chatziioannou
Michael E Phelps
Heather Christofk
James R Heath

Funding

QUANTITATIVE IMAGE ANALYSIS SPECIALIZED RESOURCE COREU54CA119347 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI SAWYERS, CHARLES L · 2005 to 2009
$17.8M
UCLA Institute for Molecular Medicine (IMED) CoreU54CA151819 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HEATH, JAMES R. · 2010 to 2014
$12.1M
The role of mTORC2 in reprogramming cancer cell metabolismR01NS073831 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MISCHEL, PAUL S · 2011 to 2020
$3.4M
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)R01CA170689 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HEATH, JAMES R., RIBAS, ANTONI · 2012 to 2015
$2.5M
NCI NIH HHS 5U54 CA119347NCI NIH HHS R01 CA170689NCI NIH HHS U54 CA119347NCI NIH HHS U54 CA151819NINDS NIH HHS NS 73831NINDS NIH HHS R01 NS073831
6 · The paper itself

Abstract

unlabelledWe report on a radiopharmaceutical imaging platform designed to capture the kinetics of cellular responses to drugs.

methodsA portable in vitro molecular imaging system comprising a microchip and a β-particle imaging camera permitted routine cell-based radioassays of small numbers of either suspended or adherent cells. We investigated the kinetics of responses of model lymphoma and glioblastoma cancer cell lines to (18)F-FDG uptake after drug exposure. Those responses were correlated with kinetic changes in the cell cycle or with changes in receptor tyrosine kinase signaling.

resultsThe platform enabled direct radioassays of multiple cell types and yielded results comparable to those from conventional approaches; however, the platform used smaller sample sizes, permitted a higher level of quantitation, and did not require cell lysis.

conclusionThe kinetic analysis enabled by the platform provided a rapid (≈ 1 h) drug screening assay.

Indexed as

Systems IntegrationBiological TransportCell Line, TumorDrug Evaluation, PreclinicalFluorodeoxyglucose F18GlycolysisHumansKineticsMiniaturizationMolecular ImagingFluorodeoxyglucose F18microfluidicsmolecular imagingradioassayradiopharmaceuticals

Identifiers

PMID23978446
PMCPMC4106462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.